#gmp standards
Discover 2 curated intelligence briefings related to this specific topic.
Health & Medicine
The Metagenomic Leap: Why 2024 is the Year of Agnostic Diagnostics
The healthcare industry is witnessing a fundamental pivot from targeted testing to metagenomic sequencing. By analyzing all genetic material in a sample, clinicians are now identifying pathogens and biomarkers that were previously invisible, slashing diagnosis times and redefining early intervention.
Read Analysis
Health & Medicine
Decentralized CRISPR Delivery Demands Absolute Protocol Rigor
Scaling CRISPR protocols outside of central academic hubs requires a ruthless commitment to GMP standards, cold-chain stability, and real-time quality control to prevent catastrophic off-target effects.
Read Analysis